[Relation of diabetic markers and tumor markers--hemoglobin A1, glycosylated albumin, glycosylated protein and CEA, CA19-9 in diabetic and cancerous patients].
D000951:Antigens, Neoplasm / Q000032:analysis*; D015295:Antigens, Tumor-Associated, Carbohydrate; D001798:Blood Proteins / Q000032:analysis*; D002272:Carcinoembryonic Antigen / Q000032:analysis*; D003920:Diabetes Mellitus / Q000175:diagnosis*; D005260:Female; D006442:Glycated Hemoglobin / Q000032:analysis*; D017127:Glycation End Products, Advanced; D006023:Glycoproteins; D006801:Humans; D008297:Male; D009369:Neoplasms / Q000175:diagnosis*; D011863:Radioimmunoassay; D012709:Serum Albumin / Q000032:analysis*; D000093422:Glycated Serum Proteins; D000093423:Glycated Serum Albumin
D000951:Antigens, Neoplasm; D015295:Antigens, Tumor-Associated, Carbohydrate; D001798:Blood Proteins; D002272:Carcinoembryonic Antigen; D006442:Glycated Hemoglobin; D017127:Glycation End Products, Advanced; D006023:Glycoproteins; D012709:Serum Albumin; D000093422:Glycated Serum Proteins; D000093423:Glycated Serum Albumin